InMed Pharmaceuticals Inc. (IMLFF) Announces Completion of Initial Phase 1 Clinical Trial
Marijuana Industry NewsUncategorized April 1, 2020
InMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN…
The post InMed Pharmaceuticals Inc. (IMLFF) Announces Completion of Initial Phase 1 Clinical Trial appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read moreInMed Pharmaceuticals Inc. (IMLFF) Reports Second Quarter Fiscal 2020 Financial Results
Marijuana Industry NewsUncategorized February 15, 2020
InMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D…
The post InMed Pharmaceuticals Inc. (IMLFF) Reports Second Quarter Fiscal 2020 Financial Results appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read moreInMed Pharmaceuticals Inc. (IMLFF) to Report Second Quarter Fiscal 2020 Financial Results
Marijuana Industry NewsUncategorized February 7, 2020
InMed Pharmaceuticals to Report Second Quarter Fiscal 2020 Financial Results and Business…
The post InMed Pharmaceuticals Inc. (IMLFF) to Report Second Quarter Fiscal 2020 Financial Results appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read moreInMed Pharmaceuticals Inc. (IMLFF) to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Uncategorized September 3, 2019
InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN;OTCQX:IMLFF), a biopharmaceutical company developing…
The post InMed Pharmaceuticals Inc. (IMLFF) to Present at the H.C. Wainwright 21st Annual Global Investment Conference appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read moreMarijuana Stocks Newsletter For September 3, 2019
Uncategorized September 3, 2019
TOP STORY: Inside Information on Marijuana Stocks What Did the Wolf Just…
The post Marijuana Stocks Newsletter For September 3, 2019 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read more
InMed Pharmaceuticals Inc. (IMLFF) to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019
Marijuana Industry NewsUncategorized May 8, 2019
InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019 InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids as well as an R&D pipeline of medications targeting diseases with high unmet medical needs, […]
The post InMed Pharmaceuticals Inc. (IMLFF) to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read more
InMed Pharmaceuticals (IMLFF) (IN) Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer
CBDHempUncategorized January 12, 2019
VANCOUVER, Jan. 11, 2019 /PRNewswire/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, today announced that Dr. Sazzad Hossain, PhD, MSc, will assume a position as member […]
The post InMed Pharmaceuticals (IMLFF) (IN) Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read more
